183 related articles for article (PubMed ID: 34065672)
21. Identification of Genes Related to Clinicopathological Characteristics and Prognosis of Patients with Colorectal Cancer.
Gao X; Yang J
DNA Cell Biol; 2020 Apr; 39(4):690-699. PubMed ID: 32027181
[TBL] [Abstract][Full Text] [Related]
22. Copy number and expression alterations of miRNAs in the ovarian cancer cell line OVCAR-3: impact on kallikrein 6 protein expression.
Bayani J; Kuzmanov U; Saraon P; Fung WA; Soosaipillai A; Squire JA; Diamandis EP
Clin Chem; 2013 Jan; 59(1):296-305. PubMed ID: 23136250
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of multiple kallikreins in high-grade astrocytoma.
Drucker KL; Gianinni C; Decker PA; Diamandis EP; Scarisbrick IA
BMC Cancer; 2015 Aug; 15():565. PubMed ID: 26231762
[TBL] [Abstract][Full Text] [Related]
24. Upregulation and secretion of kallikrein-related peptidase 6 (KLK6) in gastric cancer.
Kim JJ; Kim JT; Yoon HR; Kang MA; Kim JH; Lee YH; Kim JW; Lee SJ; Song EY; Myung PK; Lee HG
Tumour Biol; 2012 Jun; 33(3):731-8. PubMed ID: 22373580
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types.
Tailor PD; Kodeboyina SK; Bai S; Patel N; Sharma S; Ratnani A; Copland JA; She JX; Sharma A
Oncotarget; 2018 Apr; 9(25):17876-17888. PubMed ID: 29707153
[TBL] [Abstract][Full Text] [Related]
26. Kallikrein-related peptidase 6 (KLK6) expression differentiates tumor subtypes and predicts clinical outcome in breast cancer patients.
Haritos C; Michaelidou K; Mavridis K; Missitzis I; Ardavanis A; Griniatsos J; Scorilas A
Clin Exp Med; 2018 May; 18(2):203-213. PubMed ID: 29435805
[TBL] [Abstract][Full Text] [Related]
27. KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma.
White NM; Mathews M; Yousef GM; Prizada A; Popadiuk C; Doré JJ
Br J Cancer; 2009 Oct; 101(7):1107-13. PubMed ID: 19707197
[TBL] [Abstract][Full Text] [Related]
28. Multiclonal colorectal cancers with divergent histomorphological features and RAS mutations: one cancer or separate cancers?
Lin MT; Zheng G; Tseng LH; Zhang P; Ling H; Azad N; Gocke CD; Montgomery E; Eshleman JR
Hum Pathol; 2020 Apr; 98():120-128. PubMed ID: 32171651
[TBL] [Abstract][Full Text] [Related]
29. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J
Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105
[TBL] [Abstract][Full Text] [Related]
30. Kallikrein 6 protease advances colon tumorigenesis
Chen H; Sells E; Pandey R; Abril ER; Hsu CH; Krouse RS; Nagle RB; Pampalakis G; Sotiropoulou G; Ignatenko NA
Oncotarget; 2019 Oct; 10(58):6062-6078. PubMed ID: 31692974
[TBL] [Abstract][Full Text] [Related]
31. Elevated expression of KLK8 predicts poor prognosis in colorectal cancer.
Liu X; Quan B; Tian Z; Xi H; Jia G; Wang H; Zhang L; Liu R; Ma C; Han F; Li H; Yuan F
Biomed Pharmacother; 2017 Apr; 88():595-602. PubMed ID: 28142115
[TBL] [Abstract][Full Text] [Related]
32. ETV4 plays a role on the primary events during the adenoma-adenocarcinoma progression in colorectal cancer.
Fonseca AS; Ramão A; Bürger MC; de Souza JES; Zanette DL; de Molfetta GA; de Araújo LF; de Barros E Lima Bueno R; Aguiar GM; Plaça JR; Alves CP; Dos Santos ARD; Vidal DO; Silva GEB; Panepucci RA; Peria FM; Feres O; da Rocha JJR; Zago MA; Silva WA
BMC Cancer; 2021 Mar; 21(1):207. PubMed ID: 33648461
[TBL] [Abstract][Full Text] [Related]
33. An age stratified analysis of the biomarkers in patients with colorectal cancer.
Yao H; Li C; Tan X
Sci Rep; 2021 Nov; 11(1):22464. PubMed ID: 34789836
[TBL] [Abstract][Full Text] [Related]
34. In-silico analysis of kallikrein gene expression in pancreatic and colon cancers.
Yousef GM; Borgoño CA; Popalis C; Yacoub GM; Polymeris ME; Soosaipillai A; Diamandis EP
Anticancer Res; 2004; 24(1):43-51. PubMed ID: 15015574
[TBL] [Abstract][Full Text] [Related]
35. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer.
Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P
Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342
[TBL] [Abstract][Full Text] [Related]
36. Identification of a five-gene signature with prognostic value in colorectal cancer.
Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
[TBL] [Abstract][Full Text] [Related]
37. High kallikrein-related peptidase 6 in non-small cell lung cancer cells: an indicator of tumour proliferation and poor prognosis.
Nathalie HV; Chris P; Serge G; Catherine C; Benjamin B; Claire B; Christelle P; Briollais L; Pascale R; Marie-Lise J; Yves C
J Cell Mol Med; 2009 Sep; 13(9B):4014-22. PubMed ID: 19426157
[TBL] [Abstract][Full Text] [Related]
38. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
[TBL] [Abstract][Full Text] [Related]
39. Identification of hub genes in colorectal cancer based on weighted gene co-expression network analysis and clinical data from The Cancer Genome Atlas.
Zhang Y; Luo J; Liu Z; Liu X; Ma Y; Zhang B; Chen Y; Li X; Feng Z; Yang N; Feng D; Wang L; Song X
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34308980
[TBL] [Abstract][Full Text] [Related]
40. Kallikrein-related peptidase 6 regulates epithelial-to-mesenchymal transition and serves as prognostic biomarker for head and neck squamous cell carcinoma patients.
Schrader CH; Kolb M; Zaoui K; Flechtenmacher C; Grabe N; Weber KJ; Hielscher T; Plinkert PK; Hess J
Mol Cancer; 2015 May; 14():107. PubMed ID: 25990935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]